Results 81 to 90 of about 2,887 (179)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong) [PDF]

, 2017
The pill burden of patients with hypertension and dyslipidemia can result in poor medication compliance. This study aimed to evaluate the efficacy and safety of fixed-dose combination (FDC) therapy with olmesartan medoxomil (40 mg) and rosuvastatin (20 ...
최동훈
core   +1 more source

EFFECTS OF OLMESARTAN ON LOCAL AND REGIONAL RIGIDITY OF ARTERIES IN ISCHEMIC HEART DISEASE

Кардиоваскулярная терапия и профилактика, 2014
Aim. To evaluate 24-week treatment by olmesartan on rigidity of arteries in different vessel areas in patients with coronary heart disease (CHD) with 1–2 grade arterial hypertension (AH).Material and methods.
I. B. Matrosova, E. A. Melnikova, V. E. Oleynikov   +2 more
doaj   +1 more source

Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry

, 2007
A simple, rapid and reliable UV spectrophotometric method was developed for the determination of olmesartan medoxomii in pharmaceutical dosage forms. The solutions of standard, tablet and synthetic tablet were prepared in acetonitrile and in NaOH-Water ...
Celebier, MUSTAFA, Altinoz, S.
core   +1 more source

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers

Intestinal Research, 2017
Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated with the use of drugs belonging to the ...
Harshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, Amit Kumar, Manish Rathi, Surinder S Rana   +5 more
doaj   +1 more source

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy A Randomized, Double-Blind, Parallel-Group, Multicentre Study

, 2009
BACKGROUND AND OBJECTIVES: Cerebrovascular and cardiac adverse events can be significantly reduced by effective antihypertensive therapy; however, BP control rates remain poor.
VOLPE, Massimo, Uwe Haag, Peter Brommer, Cristina Miele   +3 more
core   +1 more source

Application of Capillary Electrophoresis to Investigate the Degradation Kinetic of Olmesartan Medoxomil

, 2009
A simple capillary zone electrophoresis method was applied in order to investigate the degradation of olmesartan medoxomil in basic pHs. A kinetic approach was performed to enlighten its degradation process.
ÇELEBİER, MUSTAFA, ALTINÖZ, SACİDE
core   +1 more source

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Vascular Health and Risk Management, 2011
R Preston MasonCardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and Elucida Research, Beverly, MA, USAAbstract: Cardiovascular (CV) disease is a major factor in mortality rates around the world and ...
Mason
doaj  

Effects of Angiotensin II AT1–Receptor Blockade on High Fat Diet–Induced Vascular Oxidative Stress and Endothelial Dysfunction in Dahl Salt-Sensitive Rats

Journal of Pharmacological Sciences, 2013
We examined the effects of angiotensin II AT1–receptor blockade with olmesartan on high fat (HF) diet–induced vascular oxidative stress and endothelial dysfunction in normal salt (NS) diet–fed Dahl salt-sensitive (DSS) rats.
Shinji Kosaka, Nicolas Pelisch, Matlubur Rahman, Daisuke Nakano, Hirofumi Hitomi, Hiroyuki Kobori, Noriyasu Fukuoka, Hideki Kobara, Hirohito Mori, Tsutomu Masaki, Ludek Cervenka, Yasuo Matsumura, Hitoshi Houchi, Akira Nishiyama   +13 more
doaj   +1 more source

Analysis Of Olmesartan Medoxomil, Hydrochlorothiazide, And Related Impurities In Pharmaceutical Dosage Forms By Hplc

, 2014
Çalışmamızda antihipertansif etkili ilaç etken maddeleri, Olmesartan medoksomil ve Hidroklorotiyazid ve bu etken maddelerin safsızlıklarının aynı anda tayinleri amacıyla bir Agilent 1100 serisi HPLC yöntemi geliştirilmiş ve valide edilmiştir.
SAÇINTI, Çağlar
core  

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

Clinical Interventions in Aging, 2015
Stefano Omboni,1 Ettore Malacco,2 Jean-Michel Mallion,3 Massimo Volpe4,5 1Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy; 2Department of Internal Medicine, Ospedale L Sacco, University of Milan, Milan, Italy ...
Omboni S, Malacco E, Mallion JM, Volpe M
doaj